DrugDev and Customers Promote Adoption of Modern Technology to Improve Clinical Trials at Pharmaceutical Industry Conferences in Q4

Share Article

Subject matter experts to participate on key panels at conferences in the United States and Europe

News Image
Industry-wide collaboration (including at key industry conferences) is essential to drive the necessary transformation in clinical research.

DrugDev and customers will present at several upcoming conferences during the next two months to continue to encourage the use of modern technology in clinical research. Subject matter experts will discuss how innovative and collaborative solutions transform the economics of clinical research and enable sponsors and CROs to do more trial with a reduced budget. Join the conversation at…

  •     Patient Recruitment and Retention Summit (Boston, October 21-22) – During an “Ask the Experts” segment, DrugDev Vice President of Business Development Cameron Snider will moderate a panel on new strategies and techniques to attract and engage patients. Panelists include Kelly McKee, Associate Director Clinical Research, Global Trial Optimization, Merck; Suzan Johnson, Director Global Clinical Operations, Janssen; Heather Di Benedetto, Global Head Clinical Operations OTM, Novartis; and, Mary Stober Murray, Associate Director Advocacy at Bristol-Myers Squibb.
  •     European Site Solutions Summit (Nice, France, November 2-3) – DrugDev thought leaders will participate on three expert panels: “Feasibility: Getting Selected from the Start” (Claire Sears, PhD, Director of Investigator Engagement); “The Devil Is in the Detail: The Fine Print of the Contract” (Kirsty Kwiatkowski, SiteStart Director); and “How Do You Build Your Study Budget? Hidden Costs; Exposing the Realities” (Stewart Mackie, Vice President Payments, EMEA and AP).
  •     13th Annual Strategic Resource Management Conference (Philadelphia, November 2-4) – DrugDev Chief Commercial Officer Brett Kleger will participate in the panel “Leveraging Private-Public Partnerships and Alternative Business Models to Drive Innovation in Global Health,” along with Alexandre Portet, MBA, Deputy Director, Strategy, Planning & Management, Global Health R&D, Bill & Melinda Gates Foundation; and, Chandra Ramanathan, Global Program Head, External Innovation - Life Sciences, Bayer AG. Also at the conference, Kleger will participate in the panel “Translating Innovation into Customer Value: Culture, Partnerships and Pipeline Impact.”

Earlier this month, DrugDev Vice President Kevin Williams and Contract Manager Becky Arch presented a Master Workshop, “An Insider’s Guide to Faster Site Activation and Cash Flow” at the SCRS Site Solutions Summit in Florida; and, JoAnn Ulmer, Contract Manager for DrugDev, contributed as a panelist to “The Budget Conundrum” at the MAGI West conference.

DrugDev believes industry-wide collaboration (including at key industry conferences) is essential to drive the necessary transformation in clinical research. Learn more about how DrugDev technology enables sponsors, CROs and sites to Do More Trials at drugdev.com.

About DrugDev
DrugDev enables sponsors, CROs and sites to Do More Trials through industry-wide collaboration, standardization and a beautiful technology experience. Built around the largest global network of active opted-in investigators, DrugDev’s unified solutions suite optimizes site selection and startup, investigator payments and clinical operations. DrugDev also serves as the trusted third-party host of the revolutionary Investigator Databank collaboration and powers the TransCelerate Investigator Registry (launching this year). Learn why 9 of the top 10 sponsors and 4 of the top 5 CROs rely on DrugDev technology to do more trials at drugdev.com - and connect with DrugDev on LinkedIn and Twitter to join the conversation.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Brenda Nashawaty
DrugDev
+1 617-688-3253
Email >

Kristopher Sarajian
DrugDev
617-952-4071 132
Email >
@drugdevinc
Follow >
Visit website